Diagnosticos da America (BSP:DASA3) Tax Provision: R$-528 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:DASA3 Diagnosticos da America SA BSP:DASA3
53 GF Score
Price R$2.71
GF Value R$1.69
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Diagnosticos da America Tax Provision?

Diagnosticos da America BSP:DASA3 +3.04% 53 Tax Provision is R$-528 Mil as of Mar. 2026. GuruFocus rates BSP:DASA3 with a GF Score™ of 53/100 and a GF Value™ of R$1.69 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Diagnosticos da America's tax provision for the three months ended in Mar. 2026 was R$-12 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was R$-528 Mil.

Diagnosticos da America Tax Provision Historical Data

* Premium members only.

The historical data trend for Diagnosticos da America's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnosticos da America Tax Provision Chart

Diagnosticos da America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.29 191.03 -133.82 -128.57 -521.96

Diagnosticos da America Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.76 -306.28 21.39 -230.31 -12.34
BSP:DASA3
53GF Score
Diagnosticos da America SA BSP:DASA3
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnosticos da America Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-528 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of R$-528 Mil mean?
Diagnosticos da America (BSP:DASA3) has a Tax Provision of R$-528 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Diagnosticos da America and its competitors.
Is Diagnosticos da America's Tax Provision too high?
Diagnosticos da America's current Tax Provision is R$-528 Mil. Overall, Diagnosticos da America has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Tax Provision compare to TMO and DHR?
Diagnosticos da America's Tax Provision of R$-528 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Medical Diagnostics & Research company?
A good Tax Provision depends on the Medical Diagnostics & Research industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Diagnosticos da America and its competitors. Diagnosticos da America's current Tax Provision is R$-528 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.69, compared to a current price of R$2.71 — trading 60.4% above its estimated fair value. The current Tax Provision is R$-528 Mil. Diagnosticos da America's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Tax Provision is R$-528 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued. The current stock price of R$2.71 is trading 60.4% above its estimated GF Value™ of R$1.69. GuruFocus considers Diagnosticos da America to be Significantly Overvalued.

Key valuation signals for BSP:DASA3:

  • Tax Provision: R$-528 Mil
  • GF Value™: R$1.69 vs. price of R$2.71 (60.4% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnosticos da America Business Description

Address Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
53GF Score

Get the complete analysis for BSP:DASA3

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$2.71
Price
R$1.69
GF Value